Back to Archived Journals » Biosimilars » Volume 3

Review

Clinical efficacy and safety of Tevagrastim® (XM02), a biosimilar recombinant human granulocyte colony-stimulating factor

       
Total article views   HTML views PDF downloads Totals
12,132 Dovepress* 12,132+ 2,223 14,355
Totals 12,132 2,223 14,355
*Since 27 August 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on Google Scholar